Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37436
Title: Post-alemtuzumab Graves’ disease remitting after switch to ocrelizumab
Authors: POPESCU, Veronica 
Beirinckx, Annemie
Decallonne, Brigitte
Issue Date: 2022
Publisher: 
Source: ACTA NEUROLOGICA BELGICA,
Status: Early view
Keywords: Multiple sclerosis;Alemtuzumab;Graves’ disease;Ocrelizumab;Autoimmunity;Therapeutics
Document URI: http://hdl.handle.net/1942/37436
ISSN: 0300-9009
e-ISSN: 2240-2993
DOI: 10.1007/s13760-022-01962-9
ISI #: 000798323700002
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Popescu2022_Article_Post-alemtuzumabGravesDiseaseR.pdf
  Restricted Access		Published version617.98 kBAdobe PDFView/Open    Request a copy
Show full item record

WEB OF SCIENCETM
Citations

1
checked on May 1, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.